To investigate the relationship between bronchopulmonary dysplasia and thrombocytopenia.
A prosepective case-control study ,the case were matched with 1:1according to gestational age,birth weight and admission diagnosis and divided into two groups according to the consensus definition of National Institute of Child Health and Human Development (NICHD). Platelet count, circulating megakaryocyte count, platelet activating markers (CD62P and CD63), thrombopoietin were recorded and compared in two groups, then, serial thrombopoietin levels and concomitant platelet counts were measured in infants with BPD.
Study Type
OBSERVATIONAL
Enrollment
96
It is a observation research.we didn't intervene anything.
Jie Yang
Guangzhou, Guangdong, China
Platelet counts and Circulating MK counts
Platelet counts and Circulating MK counts
Time frame: up to 4 weeks
CD62P and CD63 expression
CD62P and CD63 expression
Time frame: up to 4 weeks
TPO
Plasma TPO concentration
Time frame: up to 4 weeks
TPO and platelet
the relationship betweenTPO concentration and Platelet counts in BPD with thrombocytopenia
Time frame: up to 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.